Article

Vitrectomy for floaters can be safe, effective

Symptomatic floaters can be safely and effectively treated with vitrectomy using 25-gauge instruments, and without inducing posterior vitreous detachment or removing the anterior vitreous, said Christianne A. Wa, a third-year medical student at USC School of Medicine, Los Angeles.

Seattle-Symptomatic floaters can be safely and effectively treated with vitrectomy using 25-gauge instruments, and without inducing posterior vitreous detachment (PVD) or removing the anterior vitreous, said Christianne A. Wa, a third-year medical student at USC School of Medicine, Los Angeles.

This method can help eliminate iatrogenic retinal tears and/or detachments and also minimize the need for cataract surgery.

We basically found that we were able to reduce the risk because we did not induce PVD, Wa noted.

“We had 19% rate of cataracts which was in older patients, and none in younger patients,” Wa said. “This is considerably less than what has been seen in other studies.”

Vitrectomy has been associated with a 50% to 78% risk of developing cataracts, so this rate was considerably lower, Wa pointed out.

Floaters are more a nuisance than health concern, but patients often perceive floaters as being as serious as age-related macular degeneration or other diseases, such as glaucoma.

“Patients have a very negative perception of floaters and will to lengths to get rid of them,” Wa said. “Vitrectomy is really the only method of treating them, but there are concerns as it can lead to retinal tears and detachments, among other complications.”

They hypothesized that performing vitrectomy with 25-gauge instruments and not inducing a PVD intraoperatively would reduce the incidence of retinal tears, and that not inducing PVD and leaving the anterior vitreous intact will lower the incidence of post-vitrectomy cataract formation.

A retrospective chart review identified 66 patients who underwent 25-gauge vitrectomy for floaters, in this group, 65 had their floaters resolved. Over a period of 3 months to 4 years, none of the patients in their cohort developed retinal breaks, hemorrhage, infection, or glaucoma. And in particular, there were no retinal breaks/detachments in the 22 patients without PVD preoperatively. This is compared with 30% observed in another study, Wa said.

While none of the patients in their cohort experienced short-term complications, one patient did develop PVD and another macular pucker.

“Vitrectomy can be safe and effective,” Wa said. “If we can minimize the risk, and we should also look at the benefits.”

For more articles in this issue of Ophthalmology Times Conference Brief,click here.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.